Jason Li
Jason Li
Peter MacCallum Cancer Centre
Geverifieerd e-mailadres voor petermac.org
Geciteerd door
Geciteerd door
CONTRA: copy number analysis for targeted resequencing
J Li, R Lupat, KC Amarasinghe, ER Thompson, MA Doyle, GL Ryland, ...
Bioinformatics 28 (10), 1307-1313, 2012
A role for pericytes as microenvironmental regulators of human skin tissue regeneration
S Paquet-Fifield, H Schlüter, A Li, T Aitken, P Gangatirkar, D Blashki, ...
The Journal of clinical investigation 119 (9), 2795-2806, 2009
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles
ER Thompson, MA Doyle, GL Ryland, SM Rowley, DYH Choong, ...
PLoS Genet 8 (9), e1002894, 2012
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
TJ Parmenter, M Kleinschmidt, KM Kinross, ST Bond, J Li, MR Kaadige, ...
Cancer discovery 4 (4), 423-433, 2014
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas
SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ...
Cancer research 75 (24), 5228-5234, 2015
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
SQ Wong, J Li, AYC Tan, R Vedururu, JMB Pang, H Do, J Ellul, K Doig, ...
BMC medical genomics 7 (1), 1-10, 2014
Functional and molecular characterisation of EO771. LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer
CN Johnstone, YE Smith, Y Cao, AD Burrows, RSN Cross, X Ling, ...
Disease models & mechanisms 8 (3), 237-251, 2015
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
SJ Hogg, SJ Vervoort, S Deswal, CJ Ott, J Li, LA Cluse, PA Beavis, ...
Cell Reports 18 (9), 2162-2174, 2017
The architecture and evolution of cancer neochromosomes
DW Garsed, OJ Marshall, VDA Corbin, A Hsu, L Di Stefano, J Schröder, ...
Cancer cell 26 (5), 653-667, 2014
Splice site identification using probabilistic parameters and SVM classification
AKMA Baten, BCH Chang, SK Halgamuge, J Li
BMC bioinformatics 7 (5), 1-15, 2006
Splice site identification using probabilistic parameters and SVM classification
AKMA Baten, BCH Chang, SK Halgamuge, J Li
BMC bioinformatics 7 (5), 1-15, 2006
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage
VJ Mar, SQ Wong, J Li, RA Scolyer, C McLean, AT Papenfuss, RW Tothill, ...
Clinical Cancer Research 19 (17), 4589-4598, 2013
Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
P Blombery, ER Thompson, K Jones, GM Arnau, S Lade, JF Markham, ...
Haematologica 101 (9), e387, 2016
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
SM Hunter, MS Anglesio, GL Ryland, R Sharma, YE Chiew, SM Rowley, ...
Oncotarget 6 (35), 37663, 2015
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
GL Ryland, SM Hunter, MA Doyle, F Caramia, J Li, SM Rowley, M Christie, ...
Genome medicine 7 (1), 1-12, 2015
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families
H Thorne, AJ Willems, E Niedermayr, IMY Hoh, J Li, D Clouston, ...
Cancer Prevention Research 4 (7), 1002-1010, 2011
Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates
H Do, SQ Wong, J Li, A Dobrovic
Clinical chemistry 59 (9), 1376-1383, 2013
Inferring copy number and genotype in tumour exome data
KC Amarasinghe, J Li, SM Hunter, GL Ryland, PA Cowin, IG Campbell, ...
BMC genomics 15 (1), 1-12, 2014
Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
RW Tothill, J Li, L Mileshkin, K Doig, T Siganakis, P Cowin, A Fellowes, ...
The Journal of pathology 231 (4), 413-423, 2013
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor …
GP Risbridger, RA Taylor, D Clouston, A Sliwinski, H Thorne, S Hunter, ...
European urology 67 (3), 496-503, 2015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20